Amesite Inc. AMST
1.04
(0.01)
(0.95%)
as of 25 Sep
- Market cap
- $6.6M
- P/E
- 0.0×
Follow AMST
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| (121.49%) | (214.99%) | (146.94%) | (137.68%) |
+8 more TTM periods Free account |
|
| (112.30%) | (143.30%) | (114.92%) | (112.83%) | ||
ROIC |
(278.56%) | (538.36%) | (616.58%) | (555.97%) | |
Return on Tangible Assets |
(456.30%) | (340.99%) | (221.76%) | (171.04%) | |
Average Days of Receivables |
20.31 | 9.10 | 19.42 | 20.79 | |
Free Cash Flow per Share |
(0.48) | (0.54) | (0.59) | (0.80) | |
Free Cash Flow |
(2.22) | (2.45) | (2.70) | (2.83) | |
Capital Expenditures |
(0.29) | (0.30) | (0.32) | (0.38) | |
Piotroski F-Score |
2.00 | 3.00 | 3.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(99.09%) | (80.54%) | (59.59%) | (48.41%) | |
Accounts Receivable Turnover |
29.19 | 15.49 | 13.31 | 10.39 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
166.76% | 210.25% | 338.02% | 624.95% | |
Selling, General and Administrative Expense of Revenue |
796.81% | 911.80% | 1,486.31% | 2,733.18% | |
Share Based Compensation of Revenue |
140.88% | 91.45% | 120.35% | 204.43% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.65 | 0.73 | 0.71 | 0.68 | |
Depreciation/Fixed assets |
14.79 | 12.34 | 11.36 | 11.01 | |
Capex/Depreciation |
(0.97) | (0.90) | (0.85) | (0.87) | |
Revenue per Share |
0.07 | 0.06 | 0.04 | 0.03 | |
Operating CF per Share |
(0.42) | (0.47) | (0.52) | (0.70) | |
Capex per Share |
(0.06) | (0.06) | (0.07) | (0.11) | |
Capex to Sales |
0.86 | 1.03 | 1.64 | 3.42 | |
Net Profit Margin |
(871.71%) | (1,025.34%) | (1,731.04%) | (3,270.34%) |
Columns are period end dates